BMJ 1995;311:751 (16 September)

Letters

Meta-analysis of antidepressant prescribing

Drop out rates were presented in a misleading manner

EDITOR,--The meta-analysis by I M Anderson and B M Tomenson is an interesting development in the literature addressing the effectiveness and cost effectiveness of prescribing of antidepressants.1 The authors estimate that the risk of patients stopping treatment is 10% lower with selective serotonin reuptake inhibitors than tricyclic antidepressants. They note, however, that this corresponds to an absolute reduction in the total drop out rate of only 2.5% (their table IV) and is of borderline significance. Also, as they suggest, biases such as "patient selection, previous treatment, methodology, and study setting" may exist and make this result unreliable.

Unfortunately, although this is an apparently carefully constructed and methodologically sound paper, the results are presented misleadingly in the abstract, which states that "the total discontinuation rate was 10% lower with selective serotonin reuptake inhibitors than with tricyclic antidepressants...and the drop out rate due . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis
I M Anderson and B M Tomenson
BMJ 1995 310: 1433-1438. [Abstract] [Full Text]

This article has been cited by other articles:

  • Grace, J., Bhatti, N., Graffy, J., Ali, I. M, Martin, R. M, Hilton, S. R, Kerry, S. M, Richards, N. M (1997). GPs' perceptions of tolerability of selective serotonin reuptake inhibitors and tricyclic antidepressants. BMJ 315: 547-547 [Full text]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ